{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T09:10:28Z","timestamp":1723108228298},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1038\/s41390-020-01292-7","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T15:03:33Z","timestamp":1607958213000},"page":"444-451","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Genotype\u2013phenotype association by echocardiography offers incremental value in patients with Noonan Syndrome with Multiple Lentigines"],"prefix":"10.1038","volume":"90","author":[{"given":"Hunter","family":"Kauffman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca C.","family":"Ahrens-Nicklas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzo J. C.","family":"Calderon-Anyosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa L.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph W.","family":"Rossano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Quartermain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anirban","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"1292_CR1","first-page":"110","volume":"7","author":"RJ Gorlin","year":"1971","unstructured":"Gorlin, R. J., Anderson, R. C. & Moller, J. H. The LEOPARD (multiple lentigines) syndrome revisited. Birth Defects Orig. Artic. Ser. 7, 110\u2013115 (1971).","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"1292_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1002\/humu.23624","volume":"39","author":"AR Grant","year":"2018","unstructured":"Grant, A. R. et al. Assessing the gene\u2010disease association of 19 genes with the RASopathies using the ClinGen gene curation framework. Hum. Mutat. 39, 1485\u20131493 (2018).","journal-title":"Hum. Mutat."},{"key":"1292_CR3","doi-asserted-by":"crossref","unstructured":"Gelb, B. D. & Tartaglia, M. Noonan Syndrome with Multiple Lentigines. GeneReviews\u00ae [Internet] (eds Adam, M. P. et al.) (University of Washington, Seattle, 2007).","DOI":"10.1002\/9780470015902.a0006226"},{"key":"1292_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-13","volume":"3","author":"A Sarkozy","year":"2008","unstructured":"Sarkozy, A., Digilio, M. & Dallapiccola, B. LEOPARD syndrome. Orphanet J. Rare Dis. 3, 13 (2008).","journal-title":"Orphanet J. Rare Dis."},{"key":"1292_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0168-9525(94)90149-X","volume":"10","author":"GS Feng","year":"1994","unstructured":"Feng, G. S. & Pawson, T. Phosphotyrosine phosphatases with SH2 domains: regulators of signal transduction. Trends Genet. 10, 54\u201358 (1994).","journal-title":"Trends Genet."},{"key":"1292_CR6","doi-asserted-by":"publisher","first-page":"15436","DOI":"10.1073\/pnas.0903302106","volume":"106","author":"T Nakamura","year":"2009","unstructured":"Nakamura, T., Gulick, J., Pratt, R. & Robbins, J. Noonan Syndrome is associated with enhanced pERK activity, the repression of which can prevent craniofacial malformations. Proc. Natl Acad. Sci. USA 106, 15436\u201315441 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1292_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-019-1151-0","volume":"14","author":"G Calcagni","year":"2019","unstructured":"Calcagni, G., Digilio, M. C., Marino, B. & Tartaglia, M. Pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: the multifaceted consequences of PTPN11 mutations. Orphanet J. Rare Dis. 14, 163 (2019).","journal-title":"Orphanet J. Rare Dis."},{"key":"1292_CR8","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.febslet.2006.03.088","volume":"580","author":"N Hanna","year":"2006","unstructured":"Hanna, N. et al. Reduced phosphatase activity of SHP-2 in LEOPARD Syndrome: Consequences for PI3K binding on Gab1. FEBS Lett. 580, 2477\u20132482 (2006).","journal-title":"FEBS Lett."},{"key":"1292_CR9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/ajmg.a.36982","volume":"167a","author":"A Hahn","year":"2015","unstructured":"Hahn, A. et al. Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: palliative treatment with a rapamycin analog. Am. J. Med. Genet. A. 167a, 744\u2013751 (2015).","journal-title":"Am. J. Med. Genet. A."},{"key":"1292_CR10","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan syndrome with multiple lentigines-associated hypertrophic cardiomyopathy. PLoS ONE 12, e0178905 (2017).","DOI":"10.1371\/journal.pone.0178905"},{"key":"1292_CR11","doi-asserted-by":"crossref","unstructured":"Gross A. et al. Advancing RAS\/RASopathy therapies: an NCI-sponsored intramural and extramural collaboration for the study of RASopathies. Am. J. Med. Genet. A 182, 866\u2013876 (2020).","DOI":"10.1002\/ajmg.a.61485"},{"key":"1292_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.beem.2010.09.002","volume":"25","author":"M Tartaglia","year":"2011","unstructured":"Tartaglia, M., Gelb, B. D. & Zenker, M. Noonan syndrome and clinically related disorders. Best Pract. Res. Clin. Endocrinol. Metab. 25, 161\u2013179 (2011).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"1292_CR13","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/340847","volume":"70","author":"M Tartaglia","year":"2002","unstructured":"Tartaglia, M. et al. PTPN11 mutations in Noonan Syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am. J. Hum. Genet. 70, 1555\u20131563 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"1292_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4065\/81.4.459","volume":"81","author":"J Binder","year":"2006","unstructured":"Binder, J. et al. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clin. Proc. 81, 459\u2013467 (2006).","journal-title":"Mayo Clin. Proc."},{"key":"1292_CR15","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/j.jacc.2019.08.1057","volume":"74","author":"S Neubaur","year":"2019","unstructured":"Neubaur, S. et al. Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry. J. Am. Coll. Cardiol. 74, 2333\u20132345 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1292_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng772","volume":"29","author":"M Tartaglia","year":"2001","unstructured":"Tartaglia, M. et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29, 465\u2013468 (2001).","journal-title":"Nat. Genet."},{"key":"1292_CR17","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/jmg.40.9.704","volume":"40","author":"A Sarkozy","year":"2003","unstructured":"Sarkozy, A. et al. Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J. Med. Genet. 40, 704\u2013708 (2003).","journal-title":"J. Med. Genet."},{"key":"1292_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ajmg.a.61429","volume":"182","author":"CL Lee","year":"2020","unstructured":"Lee, C. L. et al. Cardiac manifestations and gene mutations of patients with RASopathies in Taiwan. Am. J. Med. Genet. 182, 357\u2013364 (2020).","journal-title":"Am. J. Med. Genet."},{"key":"1292_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1161\/01.RES.0000186194.06514.b0","volume":"97","author":"M Krenz","year":"2005","unstructured":"Krenz, M., Yutzey, K. E. & Robbins, J. Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1\/2 signaling. Circ. Res. 97, 813\u2013820 (2005).","journal-title":"Circ. Res."},{"key":"1292_CR20","doi-asserted-by":"publisher","first-page":"H231","DOI":"10.1152\/ajpheart.00665.2011","volume":"302","author":"C Schramm","year":"2012","unstructured":"Schramm, C., Fine, D. M., Edwards, M. A., Reeb, A. N. & Krenz, M. The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling. Am. J. Physiol. Heart Circ. Physiol. 302, H231\u2013H243 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1292_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ppedcard.2015.01.002","volume":"39","author":"BD Gelb","year":"2015","unstructured":"Gelb, B. D., Roberts, A. E. & Tartaglia, M. Cardiomyopathies in Noonan syndrome and the other RASopathies. Prog. Pediatr. Cardiol. 39, 13\u201319 (2015).","journal-title":"Prog. Pediatr. Cardiol."},{"key":"1292_CR22","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1172\/JCI44972","volume":"121","author":"TM Marin","year":"2011","unstructured":"Marin, T. M. et al. Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. J. Clin. Investig. 121, 1026\u20131043 (2011).","journal-title":"J. Clin. Investig."},{"key":"1292_CR23","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1172\/JCI44929","volume":"121","author":"X WU","year":"2011","unstructured":"WU, X. et al. MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation. J. Clin. Investig. 121, 1009\u20131025 (2011).","journal-title":"J. Clin. Investig."},{"key":"1292_CR24","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.jacc.2019.01.066","volume":"73","author":"G Andelfinger","year":"2019","unstructured":"Andelfinger, G. et al. Hypertrophic cardiomyopathy in noonan syndrome treated by MEK-inhibition. J. Am. Coll. Cardiol. 73, 2237 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1292_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1151-0","volume":"14","author":"G Calcagni","year":"2019","unstructured":"Calcagni, G., Digilio, M. C., Marino, B. & Tartaglia, M. Pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: the multifaceted consequences of PTPN11 mutations. Orphanet J. Rare Dis. 14, 163 (2019).","journal-title":"Orphanet J. Rare Dis."},{"key":"1292_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.hfc.2017.12.005","volume":"14","author":"G Calcagni","year":"2018","unstructured":"Calcagni, G. et al. Clinical presentation and natural history of hypertrophic cardiomyopathy in RASopathies. Heart Fail. Clin. 14, 225\u2013235 (2018).","journal-title":"Heart Fail. Clin."},{"key":"1292_CR27","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.bbrc.2006.10.119","volume":"351","author":"JL Theis","year":"2006","unstructured":"Theis, J. L. et al. Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 351, 896\u2013902 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1292_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jacc.2009.02.075","volume":"54","author":"JM Bos","year":"2009","unstructured":"Bos, J. M., Towbin, J. A. & Ackerman, M. J. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 54, 3 (2009).","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01292-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01292-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01292-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T20:50:17Z","timestamp":1670187017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-01292-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1292"],"URL":"https:\/\/doi.org\/10.1038\/s41390-020-01292-7","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]},"assertion":[{"value":"1 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This is a retrospective study for which consent is not required by the institutional review board of the Children\u2019s Hospital of Philadelphia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}}]}}